In Section A, members will receive diverse doses and schedules of oral ABBV-744 pill to determine Safe and sound dosing program. Extra members will be enrolled within the identified monotherapy dosign regimen. In Section B, members will get oral ruxolitinib and ABBV-744 will be presented as "increase-on" therapy. In Phase https://elliotxeqcn.ja-blog.com/31996012/a-simple-key-for-abbv-744-brd4-inhibition-in-cancer-cell-lines-unveiled